Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHSE: 603811)
Health Care · Pharmaceuticals · CN
CN¥7.40
-0.54% today · -29.3% 1Y
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHSE: 603811) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $489.59M and employs 604 people.
Over the last twelve months the share price has lost 29.3%, trading between 6.83 and 10.97.
Tweenvest scores Zhejiang Cheng Yi Pharmaceutical Co., Ltd. across four factors: quality 77/100, value 66/100, growth 43/100, dividend 82/100. Its strongest factor is dividend.
603811 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $489.59M
- Revenue (TTM)
- $120.01M
- P/E
- 16.97
- EPS
- 0.44
- Dividend yield
- 2.90%
- Beta (5Y)
- 0.07
- 52-week high
- CN¥10.97
- 52-week low
- CN¥6.83
- Avg volume (3M)
- —
- Shares outstanding
- 444.76M
- Employees
- 604
- Next earnings
- —
About Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.
- ISIN
- CNE100002YC7
- Founded
- 1966
- Listed since
- Mar 15, 2017
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.